New approaches to adjuvant therapy for patients with adverse histopathologic findings following radical prostatectomy

W. G. Nelson, J. W. Simons

Research output: Contribution to journalArticle

Abstract

Some men affected with clinically localized prostate carcinoma suffer life-threatening recurrence, despite previous treatment with surgery or radiation therapy, underscoring the need for new, effective, systemic adjuvant treatment approaches. Recent molecular mechanism based prostate cancer drug discovery efforts have identified several candidate targets for systemic prostate cancer adjuvant therapy; however, traditional cancer treatment development algorithms may not be appropriate for many of the new treatment strategies. To best exploit the clinical potential of these molecular treatment strategies, novel translational research strategies are required to support hypothesis-driven clinical research and development.

Original languageEnglish (US)
Pages (from-to)685-696
Number of pages12
JournalUrologic Clinics of North America
Volume23
Issue number4
DOIs
StatePublished - Jan 1 1996

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'New approaches to adjuvant therapy for patients with adverse histopathologic findings following radical prostatectomy'. Together they form a unique fingerprint.

  • Cite this